Related Experiment Video
Updated: Jul 14, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis
Chuan Ding1,2, Zeping Wang1, Xinyue Dou1
1School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
Abstract:
The farnesoid X receptor (FXR), a ligand-activated transcription factor, plays a crucial role in regulating bile acid metabolism within the enterohepatic circulation. Beyond its involvement in metabolic disorders and immune imbalances affecting various tissues, FXR is implicated in microbiota modulation, gut-to-brain communication, and liver disease. The liver, as a pivotal metabolic and detoxification organ, is susceptible to damage from factors such as alcohol, viruses, drugs, and high-fat diets. Chronic or recurrent liver injury can culminate in liver fibrosis, which, if left untreated, may progress to cirrhosis and even liver cancer, posing significant health risks. However, therapeutic options for liver fibrosis remain limited in terms of FDA-approved drugs. Recent insights into the structure of FXR, coupled with animal and clinical investigations, have shed light on its potential pharmacological role in hepatic fibrosis. Progress has been achieved in both fundamental research and clinical applications. This review critically examines recent advancements in FXR research, highlighting challenges and potential mechanisms underlying its role in liver fibrosis treatment.
Insights
Farnesoid X receptor (FXR) shows promise for treating liver fibrosis by modulating bile acid metabolism. Research highlights FXR’s potential in combating liver disease progression and improving therapeutic options.
Area of Science:
- Hepatology
- Molecular Biology
- Pharmacology
Background:
- The farnesoid X receptor (FXR) regulates bile acid metabolism and impacts liver health.
- Liver fibrosis, a precursor to cirrhosis and cancer, has limited FDA-approved treatments.
- FXR is involved in metabolic disorders, immune function, and liver disease.
Purpose of the Study:
- To review recent advancements in farnesoid X receptor (FXR) research for liver fibrosis.
- To explore the potential pharmacological role of FXR in treating hepatic fibrosis.
- To highlight challenges and mechanisms of FXR in liver fibrosis treatment.
Main Methods:
- Review of recent fundamental research and clinical investigations on FXR.
- Analysis of FXR's structure and its implications for drug development.
- Examination of FXR's role in bile acid metabolism and liver disease progression.
Main Results:
- FXR plays a critical role in enterohepatic circulation and liver homeostasis.
- Recent studies reveal FXR's potential as a therapeutic target for liver fibrosis.
- Progress in understanding FXR's mechanisms offers new avenues for treatment.
Conclusions:
- FXR is a promising target for developing novel therapies for liver fibrosis.
- Further research into FXR mechanisms can overcome current therapeutic limitations.
- Targeting FXR may offer a new strategy to manage liver disease progression.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Introduction to Fibroblasts
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...

